412 results on '"McFadden, Eugene"'
Search Results
2. Intravascular ultrasound-guided versus angiography-guided percutaneous coronary intervention in unprotected left main coronary artery disease: A systematic review
3. Rationale and design of the PARTHENOPE trial: A two-by-two factorial comparison of polymer-free vs biodegradable-polymer drug-eluting stents and personalized vs standard duration of dual antiplatelet therapy in all-comers undergoing PCI
4. Ticagrelor Monotherapy Versus Dual-Antiplatelet Therapy After PCI: An Individual Patient-Level Meta-Analysis
5. Independence of clinical events committees: A consensus statement from clinical research organizations
6. Uso de registros cardiovasculares en procesos regulatorios: perspectivas del Colaboratorio Cardiovascular EU-MDR
7. Use of cardiovascular registries in regulatory pathways: perspectives from the EU-MDR Cardiovascular Collaboratory
8. Use of cardiovascular registries in regulatory pathways : perspectives from the EU-MDR Cardiovascular Collaboratory
9. Periprocedural Myocardial Injury: Pathophysiology, Prognosis, and Prevention
10. Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting
11. Impact of Periprocedural Myocardial Biomarker Elevation on Mortality Following Elective Percutaneous Coronary Intervention
12. Critical Appraisal of Contemporary Clinical Endpoint Definitions in Coronary Intervention Trials: A Guidance Document
13. Defining Staged Procedures for Percutaneous Coronary Intervention Trials: A Guidance Document
14. Effects of neuropeptide Y on coronary artery vasomotion in patients with microvascular angina
15. Detecting Periprocedural Myocardial Infarction in Contemporary Percutaneous Coronary Intervention Trials
16. Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: The COMPARE Trial (A Trial of Everolimus-Eluting Stents and Paclitaxel Stents for Coronary Revascularization in Daily Practice)
17. Comparison of Short- and Long-Term Cardiac Mortality in Early Versus Late Stent Thrombosis (from Pooled PROTECT Trials)
18. Zotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates
19. P2Y12 Inhibitor or Aspirin Monotherapy for Secondary Prevention of Coronary Events
20. Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug‐Eluting Stent Implantation: Per‐Protocol Analysis of the GLOBAL LEADERS Trial
21. Oncogenes after Angioplasty
22. 2-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice: COMPARE (Comparison of the everolimus eluting XIENCE-V stent with the paclitaxel eluting TAXUS LIBERTÉ stent in all-comers: a randomized open label trial)
23. The Importance of Using the Appropriate Model for Systematic Reviews and Meta-analyses
24. Rotational atherectomy
25. Coronary angioscopy — An inner view
26. Rotational atherectomy — An overview
27. Quantitative assessment of the residual stenosis after percutaneous transluminal cororonary rotary ablation: European Experience
28. Chronic myocardial infarction detection and characterization during coronary artery calcium scoring acquisitions
29. Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial
30. Prosthetic valve endocarditis after transcatheter aortic valve replacement in low‐risk patients
31. Four-Year Follow-Up of Absorb BVS Compared to Xience EES in Daily Clinical Practice Shows Continued Accrual of Events
32. Comparison of Investigator-Reported and Clinical Event Committee-Adjudicated Outcome Events in GLASSY
33. Reply: Periprocedural PCI Myocardial Biomarker Elevation and Mortality
34. Rationale and methods of the integrated biomarker and imaging study (IBIS): combining invasive and non-invasive imaging with biomarkers to detect subclinical atherosclerosis and assess coronary lesion biology
35. Clinical effectiveness of bare-metal stenting compared with balloon angioplasty in total coronary occlusions: insights from a systematic overview of randomized trials in light of the drug-eluting stent era
36. Comparison of Investigator-Reported and Clinical Event Committee–Adjudicated Outcome Events in GLASSY
37. Classification and Current Treatment Options of In-Stent Restenosis: Present Status and FuturePerspectives
38. 'Full metal jacket' (stented length (greater than or equal to) 64 mm) using drug-eluting stents for de novo coronary artery lesions
39. Tirofiban and sirolimus-eluting stent vs. abciximab and bare-metal stent for acute myocardial infarction
40. Is hormonal activation during exercise useful for risk stratification in patients with moderate congestive heart failure?
41. Dobutamine-tagged MRI for inotropic reserve assessment in severe CAD: relationship with PET findings
42. Cardiovascular Clinical Trials in a Pandemic: Immediate Implications of Coronavirus Disease 2019
43. Four-Year Follow-Up of Absorb BVS Compared to Xience EES in Daily Clinical Practice Shows Continued Accrual of Events
44. Reply
45. Noninvasive Assessment of Coronary Plaque Burden Using Multislice Computed Tomography
46. Impact of baseline renal function on mortality after percutaneous coronary intervention with sirolimus-eluting stents or bare metal stents
47. “Full metal jacket” (stented length ≥64 mm) using drug-eluting stents for de novo coronary artery lesions
48. Prosthetic valve endocarditis after transcatheter aortic valve replacement in low‐risk patients.
49. Adjunctive value of CT coronary angiography in the diagnostic work-up of patients with typical angina pectoris
50. Indication of long-term endothelial dysfunction after sirolimus-eluting stent implantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.